KAISER LIPID GUIDELINES INCREASE DRUG SPEND BY $12,000 PER MONTH, PHARMACIST TELLS AMCP; PHARMACY GOLD ENCOURAGING PHYSICIANS TO TRY LESCOL FOR 3-6 MONTHS
Kaiser-Permanente's Rocky Mountain Division is spending $12,000 more per month on lipid-lowering drugs since the dissemination of a cholesterol guideline in late 1996, clinical pharmacy specialist Susyn Plushner told the Academy of Managed Care Pharmacy annual meeting May 8 in New Orleans.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth